Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
West Carroll School Board Administers Oath of Office, Approves Policy???
6+ day, 14+ hour ago (820+ words) ATWOOD (September 3) — The West Carroll Special School District Board of Education convened on September...During the administrative reports, district officials highlighted recent successes and ongoing challenges...The high school reported meeting its achievement and growth goals....
Regeneron Pharmaceuticals, Inc. Notice of September 14, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline
3+ week, 2+ day ago (604+ words) combination with Libtayo as a first-line treatment for metastatic or locally advanced melanoma (the "Study...The Study's primary endpoint was progression-free survival ("PFS") and Regeneron has characterized the...
AVEX EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds AEVEX Investors of Securities Class Action Lawsuit Deadline on October 20, 2026
2+ week, 5+ day ago (219+ words) On Tuesdays and Saturdays, see special digital-only news â along with entertainment, TV listings, comics... in a newspaper-style format. - Jail time looms for ex Methuen police chief - Former students report...sexual abuse by ex-Phillips physician - An extra special return to…...
REGN Shareholder Alert: September 14, 2026 Lead Plaintiff Deadline in Regeneron Pharmaceuticals Securities Class Action - Contact SueWallSt
3+ week, 3+ day ago (684+ words) This Regeneron analyst reaction focuses on analysts' reassessment of the Phase III Fianlimab-Libtayo Study...a prolonged slowdown in progression-free survival event accrual in the Phase III Fianlimab-Libtayo Study...Analysts allegedly reacted to that disclosure as a meaningful change in the…...
MONDAY REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 14, 2026 Deadline - RGRD Law
6+ day, 3+ hour ago (175+ words) s first quarter earnings call, defendants allegedly disclosed that the Phase III Fianlimab-Libtayo Study...had been altered, expanding the number of patients in the study eligible for “analysis of progression-free...
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
1+ mon, 1+ week ago (375+ words) Raise On December 3, 2025 Capricor announced "Positive Topline Results from Pivotal Phase 3 HOPE-3 Study...Stock Collapse In contrast to Capricor's December claims, the FDA said in the brief that the HOPE-3 study...
Board of Education to consider final approval of revisions to the Code of Student Conduct and attendance policy
2+ week, 1+ day ago (385+ words) The proposed revision allows the district to utilize a state attendance code to excuse particular absences...The board will also consider the first reading of multiple policies that are from a special Summer 2026...
Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR
1+ week, 2+ day ago (290+ words) As a result, the FDA stated that it "considers [Capricor's] analyses based on the post-study SAP versions...
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28 Deadline
4+ day, 18+ hour ago (330+ words) Advisory Committee meeting and includes 24-month open-label extension data from the Phase 3 HOPE-3 study...
HIMS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Hims Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
1+ week, 5+ day ago (991+ words) We welcome the opportunity to discuss your particular case....